Our Team

Spanning both CU Denver and the Anschutz Medical Center.

Jim Grigsby

Jim Grigsby

Executive Director
Center for Psychedelic Research
Jim Grigsby is a neuroscientist and clinical psychologist/neuropsychologist at CU Denver. His research has been funded since 1992 by NIH, Medicare, HRSA, the Department of Defense, and other federal and private agencies and foundations. He is co-editor of the Handbook of Medical Hallucinogens.
Jim.Grigsby@ucdenver.edu
Shandra Brown Levey, PhD

Shandra Brown Levey, PhD

Associate Director 
Center for Psychedelic Research
Shandra Brown Levey is a clinical psychologist and associate professor. With more than a decade of experience designing and directing integrated behavioral health clinical, research, and training programs, she believes in creating synergy with existing program needs and the emerging field of psychedelic-assisted therapies. She also champions for access for underserved populations and strategic innovation across complex systems.
SHANDRA.BROWNLEVEY@CUANSCHUTZ.EDU
Laura Argys, PhD

Laura Argys, PhD

Policy Researcher
Center for Psychedelic Research
Laura Argys is a Professor of Economics at CU Denver specializing in labor and health economics. She conducts research on the decision-making and behavioral response to policies focused on health, education and poverty. the effects of policy on child well-being. She brings her health economics expertise to Center’s research looking at psychedelic use and legislative change.
Laura.Argys@ucdenver.edu
Stacy Fischer MD

Stacy Fischer, MD

Medical Director and Director of Clinical Trials
Center for Psychedelic Research
Stacy Fischer is a Professor of General Internal Medicine and a board-certified Geriatrician and Palliative Care clinician. She is also a Program Leader in Cancer Prevention and Control at the CU Comprehensive Cancer Center and co-directs the T32 Multidisciplinary Palliative Care Research Post-Doctoral training program. Her research focuses on improving palliative care outcomes for underserved and vulnerable populations.
STACY.FISCHER@CUANSCHUTZ.EDU
No Headshot

Christopher Lowry, PhD

Basic/Translational Science Researcher
Center for Psychedelic Research
Christopher Lowry is a Professor in the Department of Integrative Physiology at CU Boulder. He is interested in the therapeutic potential of psychedelics and how these substances interact with the gut-brain axis and influence neuroinflammation as possible treatments for mood and anxiety disorders. His research combines preclinical studies with translational approaches, with the goal of using basic scientific findings to develop new therapeutic strategies.
CHRISTOPHER.LOWRY@UCDENVER.EDU
Vivian Shy PhD

Vivian Shyu, PhD

Director of Education 
Center for Psychedelic Research
Vivian Shyu is a teaching professor in CU Denver’s Psychology Department with research focused on psychedelic drug use and legislative change. As a trained psychedelic-assisted facilitator, she applies her expertise in cognitive psychology and neuroscience to the development of robust training programs, with the aim of ensuring safe and effective practices in this evolving field.
Vivian.Shyu@ucdenver.edu
No Headshot

Molly Sullan, PhD

Director of Clinical Research
Center for Psychedelic Research
Molly Sullan is a clinical research neuropsychologist at the CU Anschutz Medical Campus and is a licensed clinical neuropsychologist. Her research focuses on clinical and biological outcomes following traumatic brain injury, military-related repetitive blast exposure, and toxic exposures in the military. She is currently co-authoring publications and helping to design research protocols related to psychedelic-assisted treatments for neurological disorders with UCDCPR colleagues.
MOLLY.SULLAN@UCDENVER.EDU